NEUK203-13

· Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NEUK203-13, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients [Phase 1]